Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00496431
Brief Title: phII Study of an HDAC Inhibitor in Very High-risk Relapsed/Refractory Hodgkin's Lymphoma Patients

First Submitted : July 3, 2007
First Submitted that Met QC Criteria : July 3, 2007
First Posted : July 4, 2007 (Estimate)

Last Update Submitted that Met QC Criteria : May 23, 2013
Last Update Posted : May 24, 2013 (Estimate)